SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?


To: zeta1961 who wrote (187)1/12/2005 11:28:43 PM
From: fred hayesRead Replies (1) | Respond to of 802
 
Zeta, FWIW ("when that occurred"): AUSTIN, TX - Aug. 4, 1999 - Introgen Therapeutics, Inc., a world leader in the development of gene-based therapeutics, today announced that Corixa Corporation (Nasdaq: CRXA), a research- and development-based biotechnology company, has granted Introgen an exclusive worldwide license to the patented universal tumor suppressor gene, mda7, for use in gene therapy."

fred